Site-Directed Mutagenesis: Advancing T-Cell Receptor Research
The innovation discloses a novel genetic technique in the area of applied immunology and oncology. With that approach we were able to harness human T-cells with tumor antigen-specific T-cell receptors so as to increase specific recognition of tumor antigens and lyses of target and malignant cells.
Further Information: PDF
IMG Innovations-Management GmbH
Phone: +49 (0)631/31668-0
Contact
Dr. Klaus Kobek
